334
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Diagnostic Accuracy and Interobserver Variability of Pulsed Arterial Spin Labeling for Glioma Grading

, , , &
Pages 450-457 | Published online: 09 Jul 2009

References

  • Leon SP, Folkerth RD, Black P. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996; 77: 362–72
  • Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Papadakis N, Varakis I. Microvessel density in brain tumors. Anticancer Res 1997; 17: 4747–54
  • Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, et al. Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. Br J Radiol 2003; 76(Suppl 1)S87–91
  • Akella NS, Twieg DB, Mikkelsen T, Hochberg FH, Grossman S, Cloud GA, et al. Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trial. J Magn Reson Imaging 2004; 20: 913–22
  • Kimura H, Takeuchi H, Koshimoto Y, Arishima H, Uematsu H, Kawamura Y, et al. Perfusion imaging of meningioma by using continuous arterial spin-labeling: comparison with dynamic susceptibility-weighted contrast-enhanced MR images and histopathologic features. Am J Neuroradiol 2006; 27: 85–93
  • Law M, Oh S, Babb JS, Wang E, Inglese M, Zagzag D, et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging—prediction of patient clinical response. Radiology 2006; 238: 658–67
  • Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. Am J Neuroradiol 2004; 25: 746–55
  • Barbier EL, Lamalle L, Decorps M. Methodology of brain perfusion imaging. J Magn Reson Imaging 2001; 13: 496–520
  • Law M, Yang S, Wang H, Bab JS, Johnson G, Cha S, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 2003; 24: 1989–98
  • Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994; 193: 637–41
  • Calamante F, Thomas DL, Pell GS, Wiersma J, Turner R. Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab 1999; 19: 701–35
  • Warmuth C, Günther M, Zimmer C. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology 2003; 228: 523–32
  • Daumas-Duport C, Beuvon F, Varlet P, Fallet-Bianco C. Gliomas: WHO and Sainte-Anne Hospital classifications. Ann Pathol 2000; 20: 413–28
  • Dean BL, Drayer BP, Bird CR, Flom RA, Hodak JA, Coons SW, et al. Gliomas: classification with MR imaging. Radiology 1990; 174: 411–5
  • Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992; 34: 463–9
  • Wetzel SG, Cha S, Johnson G, Lee P, Law M, Kasow DL, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002; 224: 797–803
  • Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–74
  • Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191: 41–51
  • Donahue KM, Krouwer HG, Rand SD, Pathak AP, Marszalkowski CS, Censky SC, et al. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000; 43: 845–53
  • Barker F, Chang S, Huhn S. Age and the risk of anaplasia in magnetic resonance non-enhancing supratentorial cerebral tumors. Cancer 1997; 80: 936–41
  • Chamberlain M, Murovic J, Levin V. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 1988; 38: 1371–4
  • Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I. Mathematical approach and statistical analysis. Magn Reson Med 1996; 36: 715–25
  • Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II. Experimental comparison and preliminary results. Magn Reson Med 1996; 36: 726–36
  • Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998; 40: 383–96
  • Lia TQ, Guang CZ, Ostergaard L, Hindmarsh T, Moseley ME. Quantification of cerebral blood flow by bolus tracking and artery spin tagging methods. Magn Reson Imaging 2000; 18: 503–12
  • Hunsche S, Sauner D, Schreiber WG, Oelkers P, Stoeter P. FAIR and dynamic susceptibility contrast-enhanced perfusion imaging in healthy subjects and stroke patients. J Magn Reson Imaging 2002; 16: 137–46
  • Krabbe K, Gideon P, Wang P, Hansen U, Thomsen C, Madsen F. MR diffusion imaging of human intracranial tumors. Neuroradiology 1997; 39: 483–9
  • Jackson RJ, Fuller GN, Abi-Said D, Lang FF, Gokaslan ZL, Shi WM, et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol 2001; 3: 193–200

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.